Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Button Text
Genetic diagnosis can lead to management changes in up to 72% of patients,2 providing insight for medication selection, dietary management, care coordination, and prognosis, as well as unlocking opportunities for clinical trial participation for patients with underlying conditions linked with genetic factors, such as Dravet, KCNQ2, SYNGAP1, and other rare developmental and epileptic encephalopathies (DEEs).
A healthcare provider may successfully fight through multiple rounds of insurance approvals only to have a patient decline genetic testing due to prohibitive out-of-pocket costs. Moreover, insurance may only cover limited testing that fails to identify the underlying genetic cause.
As part of our mission to accelerate diagnosis for rare disease patients, we provide genetic counseling and testing at no cost to eligible patients, without insurance hassles for you and your staff. Appointments can be made with our team within a week, freeing you from scheduling constraints that often limit the accessibility of local genetics specialists. We maintain transparent lines of communication with you, so that you always know what’s going on with your patient.
By answering just a couple of quick questions, you can tell us if you have eligible patients. If so, we will be in touch to set up time to tell you more about how to make AmbitCare available in your practice. If not, we are continually growing our program, so we will keep you updated if our criteria expand to include other patients you may have in your practice.
Musante L, Costa P, Zanus C, Faletra F, Murru FM, BiancoAM, La Bianca M, Ragusa G, Athanasakis E, d’Adamo AP, Carrozzi M, Gasparini P. The Genetic Diagnosis of Ultrarare DEEs: An Ongoing Challenge. Genes. 2022;13(3):500.
Haviland, I., Daniels, C., Greene, C., et al. Genetic Diagnosis in Pediatric Epilepsy Impacts Medical Management AES 2021; Abstract 2.319.
